Abstract
The results of study on the sleep–wakefulness cycle in experimental models of the preclinical and early clinical stages of Parkinson’s disease are presented and compared with clinical examples. The conclusion is made that the enhancement of behavioral activity and decrease in the total duration of the slow-wave and paradoxical sleep in model animals occur at the same circadian period of the secretion of pineal melatonin as sleep disorders in patients.
Similar content being viewed by others
References
Osipov, Yu.S., Foreword, in Mozg. Fundamental’nye i prikladnye problemy (The Brain: Basic and Applied Problems), Moscow: Nauka, 2010, p. 3. (In Russian)
Saks, O., Probuzhdeniya (Awakenings), Moscow: Astrel’, 2013. (Russian translation)
Ugrumov, M.V., Regulatory functions of the brain: From the genome to behavior, in Mozg. Fundamental’nye i prikladnye problemy (The Brain: Basic and Applied Problems), Moscow: Nauka, 2010, p. 29. (In Russian)
Ugrumov, M.V., Traditional and new notions on the pathogenesis, diagnosis, and treatment of neurodegenerative diseases, in Neirodegenerativnye zabolevaniya. Fundamental’nye i prikladnye aspekty (Neurodegenerative Diseases: Basic and Applied Aspects), Ugrumov, M.V., Ed., Moscow: Nauka, 2010, p. 8. (In Russian)
Kovalzon, V.M. and Zavalko, I.M., The neurochemistry of wakefulness–sleep cycle and Parkinson’s disease, Neurochemical Journal, 2013, vol. 30, no. 3, p. 171.
Kovalzon, V.M., Zavalko, I.M., and Dorokhov, V.B., Parkinson’s disease, the brain dopaminergic system, and sleep regulation, in Neirodegenerativnye zabolevaniya: ot genoma do tselostnogo organizma (Neurodegenerative Diseases: from the Genome to the Whole Body), Ugrumov, M.V., Ed., Moscow: Nauka, 2014, vol. 1, p. 136. (In Russian)
Kovalzon, V.M., Osnovy somnologii. Fiziologiya i neirokhimiya tsikla bodrstvovanie-son mlekopitayushchikh (Principles of Somnology: The Physiology and Biochemistry of Wakefulness–Sleep Cycle in Mammals), Moscow: Binom. Laboratoriya Znanii, 2011. (In Russian)
Kovalzon, V.M., Central mechanisms of the sleep–wakefulness cycle control, Hum. Physiol., 2011, vol. 37, no. 4, p. 500.
Kovalzon, V.M., The role of histaminergic system of the brain in the regulation of sleep–wakefulness cycle, Hum. Physiol., 2013, vol. 39, no. 7, p. 574.
Gusev, E.I., Gekht, A.B., Popov, G.R., et al., Parkinson’s disease: Clinical signs, diagnosis, and treatment, in Neirodegenerativnye zabolevaniya. Fundamental’nye i prikladnye aspekty (Neurodegenerative Diseases: Basic and Applied Aspects), Ugrumov, M.V., Ed., Moscow: Nauka, 2010, p. 52. (In Russian)
Iranzo, A., Sleep–wake changes in the premotor stage of Parkinson disease, J. Neurol. Sci., 2011, vol. 310, p. 283.
Yokoyama, H., Kuroiwa, H., Kasahara, J., and Araki, T., Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1.2,3.6-tetrahydropyridine)induced mouse model of Parkinson’s disease, Acta Neurobiol. Exp., 2011, vol. 71, p. 269.
Giovanni, A., Sieber, B.A., Heikkila, R.E., and Sonsalla, P.K., Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1.2,3.6-tetrahydropyridine. Part 1: Systemic administration, J. Pharmacol. Exp. Ther., 1994, vol. 270, no. 3, p. 1000.
Khaindrava, V.G., Kozina, E.A., Kucheryanu, V.G., et al., Modeling the preclinical and early clinical stages of Parkinson’s disease, Zh. Nevrol. Psikhiatrii, 2010, vol. 110, no. 7, p. 41. (In Russian, English summary)
Ugrumov, M.V., Khaindrava, V.G., Kozina, E.A., et al., Modeling of presymptomatic and symptomatic stages of parkinsonism in mice, Neuroscience, 2011, vol. 181, p. 175.
Manolov, A.I., Dolgikh, V.V., Ukraintseva, Yu.V., et al., Changes in the motor activity and wakefulness–sleep cycle in the MPTP model of Parkinson’s disease in mice, Ros. Fiziol. Zh., 2014, vol. 100, no. 11, p. 1252. (In Russian, English summary)
Carskadon, M.A. and Dement, W.C., Normal human sleep: An overview, in Principles and Practice of Sleep Medicine, Kryger, M.H., Roth, T., and Dement, W.C., Eds., St. Louis: Elsevier/Saunders, 2011, p. 16.
Shpirer, I., Miniovitz, A., Klein, C., et al., Excessive daytime sleepiness in patients with Parkinson’s disease: A polysomnography study, Mov. Dis., 2006, vol. 21, no. 9, p. 1432.
Bordet, R., Devos, D., Brique, S., et al., Study of circadian melatonin secretion pattern at different stages of Parkinson’s disease, Clin. Neuropharmacol., 2003, vol. 26, no. 2, p. 65.
Bolitho, S.J., Naismith, S.L., Rajaratnam, S.M.W., et al., Disturbances in melatonin secretion and circadian sleep–wake regulation in Parkinson disease, Sleep Med., 2014, vol. 15, p. 342.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.M. Kovalzon, M.V. Ugrumov, T.S. Pronina, V.B. Dorokhov, A.I. Manolov, V.V. Dolgikh, Y.V. Ukraintseva, L.S. Moiseenko, M.G. Poluektov, A.L. Kalinkin, 2015, published in Fiziologiya Cheloveka, 2015, Vol. 41, No. 6, pp. 114–118.
Rights and permissions
About this article
Cite this article
Kovalzon, V.M., Ugrumov, M.V., Pronina, T.S. et al. Early stages of Parkinson’s disease: comparative characteristics of sleep–wakefulness cycle in patients and model animals. Hum Physiol 41, 667–671 (2015). https://doi.org/10.1134/S0362119715040106
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0362119715040106